What is the main mechanism of action of tamoxifen in treating breast cancer?

• A. Competitive inhibition of estradiol activation
• B. Competitive inhibition of estradiol binding to its receptor
• C. Competitive inhibition of estradiol synthase
• D. Downregulation of estrogen receptors

Answer: (B)

Tamoxifen primarily acts as a selective estrogen receptor modulator (SERM). Its main mechanism of action is through competitive inhibition of estradiol binding to the estrogen receptor. By binding to these receptors, tamoxifen blocks the effects of estrogen in breast tissue, which is particularly important in estrogen receptor-positive breast cancers. This blockage prevents estrogen from stimulating cancer cell proliferation and growth, effectively inhibiting the progression of the disease.

In addition to its competitive binding properties, tamoxifen can have mixed effects in different tissues—acting as an estrogen agonist in some tissues (like bone and the endometrium) while exerting antagonist effects in breast tissue. This unique mechanism makes it a critical treatment option for patients with estrogen receptor-positive breast cancer, as it specifically targets the malignant cells while preserving some estrogenic activity in other parts of the body.